Progress in pharmacological and clinical studies of miriplatin on interventional therapy of hepatocellular carcinomaZHAO Jun, MA Jun-jie2097-2099
Drug risk communication method of America and Canada and its implication in ChinaLI Shan, YANG Yue2104-2108
A survey analysis of the knowledge-attitude-practice (KAP) of essential drugs in the view of patientsMA Jin-hua, XI Xiao-yu, CHU Shu-zhen2109-2112,2120
ARO-CRO-SMO,a new better model serving clinical researchCHEN Jun-chao, LIU Hong-xia, L(U) Ying-hua, ZHENG Qing-shan2113-2116
Key problem in clinical trials of the new traditional Chinese medicine to treat primary osteoporosisWANG Ting2126-2127,2136
US FDA's regulatory system for drug manufacturing qualityHAN Liang, Nicholas Buhay, ZHENG Qiang2128-2136
Determination of L-isoleucine methyl ester hydrochloride in L-valine methyl ester hydrochloride by HPLCYIN Jing, CHANG Yan2137-2140